ArticleHaematologica2025
Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy.
Francesca Sillito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it